Breast Cancer Research | Volume 12 Issue 3

Submit a manuscript Register Follow us on

Explore journal

Articles

	Volume 12 Issue 3
	Comment
	Editorial At last, a predictive and prognostic marker for radiotherapy? Philip Coates, John Dewar, Alastair M Thompson Breast Cancer Research 2010, 12:106 (11 May 2010) Abstract \| Full text \| PDF \| PubMed
	Editorial Breast tumors: of mice and women Sean P McDermott, Max S Wicha Breast Cancer Research 2010, 12:108 (27 May 2010) Abstract \| Full text \| PDF \| PubMed
	Editorial What do we learn from HER2-positive breast cancer genomic profiles? Charles Theillet Breast Cancer Research 2010, 12:107 (1 June 2010) Abstract \| Full text \| PDF \| PubMed
	Editorial Just when you thought it was safe to go into the membrane: the growing complexities of extra-nuclear progesterone signaling Aritro Sen, Stephen R Hammes Breast Cancer Research 2010, 12:109 (16 June 2010) Abstract \| Full text \| PDF \| PubMed
	Editorial Managing bone mineral density with oral bisphosphonate therapy in women with breast cancer receiving adjuvant aromatase inhibition Catherine Van Poznak Breast Cancer Research 2010, 12:110 (18 June 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	Review
	Review Tumour-associated carbohydrate antigens in breast cancer Aurélie Cazet, Sylvain Julien, Marie Bobowski, Joy Burchell, Philippe Delannoy Breast Cancer Research 2010, 12:204 (8 June 2010) Abstract \| Full text \| PDF \| PubMed
	Review The contribution of dynamic stromal remodeling during mammary development to breast carcinogenesis Jessica McCready, Lisa M Arendt, Jenny A Rudnick, Charlotte Kuperwasser Breast Cancer Research 2010, 12:205 (17 June 2010) Abstract \| Full text \| PDF \| PubMed
	Review Key signalling nodes in mammary gland development and cancer. The Snail1-Twist1 conspiracy in malignant breast cancer progression Ellen Foubert, Bram De Craene, Geert Berx Breast Cancer Research 2010, 12:206 (25 June 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	Research
	Research article High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer Johan Staaf, Göran Jönsson, Markus Ringnér, Johan Vallon-Christersson, Dorthe Grabau, Adalgeir Arason, Haukur Gunnarsson, Bjarni A Agnarsson, Per-Olof Malmström, Oskar Johannsson, Niklas Loman, Rosa B Barkardottir, Åke Borg Breast Cancer Research 2010, 12:R25 (6 May 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| Editor’s summary A survey of copy number alterations in HER2+ breast tumors using a combination of array comparative genomic hybridization and gene expression analyses pinpoints significant genomic aberrations, including potentially novel therapeutic targets.
	Research article Cyclophosphamide- metabolizing enzyme polymorphisms and survival outcomes after adjuvant chemotherapy for node-positive breast cancer: a retrospective cohort study Priya P Gor, H Irene Su, Robert J Gray, Phyllis A Gimotty, Michelle Horn, Richard Aplenc, William P Vaughan, Martin S Tallman, Timothy R Rebbeck, Angela DeMichele Breast Cancer Research 2010, 12:R26 (10 May 2010) Abstract \| Full text \| PDF \| PubMed
	Research article Inhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cells Luisa Paris, Serena Cecchetti, Francesca Spadaro, Laura Abalsamo, Luana Lugini, Maria Elena Pisanu, Egidio Iorio, Pier Giorgio Natali, Carlo Ramoni, Franca Podo Breast Cancer Research 2010, 12:R27 (12 May 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	Research article Incorporating tumour pathology information into breast cancer risk prediction algorithms Nasim Mavaddat, Timothy R Rebbeck, Sunil R Lakhani, Douglas F Easton, Antonis C Antoniou Breast Cancer Research 2010, 12:R28 (18 May 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| Editor’s summary Including tumour pathology information in breast cancer prediction models influences the predicted probabilities of carrying a BRCA1 or BRCA2 mutation and may have implications for genetic testing and clinical decision making.
	Research article Novel design principles enable specific targeting of imaging and therapeutic agents to necrotic domains in breast tumors Liat Goldshaid, Efrat Rubinstein, Alexander Brandis, Dadi Segal, Noa Leshem, Ori Brenner, Vyacheslav Kalchenko, Doron Eren, Tamar Yecheskel, Yoseph Salitra, Yoram Salomon, Avigdor Scherz Breast Cancer Research 2010, 12:R29 (24 May 2010) Abstract \| Full text \| PDF \| PubMed
	Research article Breast cancer-specific mutations in CK1ε inhibit Wnt/β-catenin and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell adhesion and promote cell migration Silvie Foldynová-Trantírková, Petra Sekyrová, Kateřina Tmejová, Eva Brumovská, Ondřej Bernatík, Wulf Blankenfeldt, Pavel Krejčí, Alois Kozubík, Tomáš Doležal, Lukáš Trantírek, Vítězslav Bryja Breast Cancer Research 2010, 12:R30 (27 May 2010) Abstract \| Full text \| PDF \| PubMed
	Research article Senescence evasion by MCF-7 human breast tumor-initiating cells Feridoun Karimi-Busheri, Aghdass Rasouli-Nia, John R Mackey, Michael Weinfeld Breast Cancer Research 2010, 12:R31 (2 June 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| Editor’s summary Understanding the inherent down-regulation of senescence pathways that offer breast cancer tumour-initiating cells protection against ionising radiation may help characterise the cellular pathways used by cancer stem cells to enhance survival.
	Research article Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-α and survivin Kathryn E Vanderlaag, Susan Hudak, Laura Bald, Laurence Fayadat-Dilman, Manjiri Sathe, Jeff Grein, Mary J Janatpour Breast Cancer Research 2010, 12:R32 (4 June 2010) Abstract \| Full text \| PDF \| PubMed
	Research article Prospectively measured triiodothyronine levels are positively associated with breast cancer risk in postmenopausal women Ada Tosovic, Anne-Greth Bondeson, Lennart Bondeson, Ulla-Britt Ericsson, Johan Malm, Jonas Manjer Breast Cancer Research 2010, 12:R33 (11 June 2010) Abstract \| Full text \| PDF \| PubMed
	Research article Progesterone reverses the mesenchymal phenotypes of basal phenotype breast cancer cells via a membrane progesterone receptor mediated pathway Lian Zuo, Wei Li, Shaojin You Breast Cancer Research 2010, 12:R34 (11 June 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	Research article Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort Huiyan Ma, Katherine D Henderson, Jane Sullivan-Halley, Lei Duan, Sarah F Marshall, Giske Ursin, Pamela L Horn-Ross, Joan Largent, Dennis M Deapen, James V Lacey, Leslie Bernstein Breast Cancer Research 2010, 12:R35 (18 June 2010) Abstract \| Full text \| PDF \| PubMed
	Research article Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns Karolina Holm, Cecilia Hegardt, Johan Staaf, Johan Vallon-Christersson, Göran Jönsson, Håkan Olsson, Åke Borg, Markus Ringnér Breast Cancer Research 2010, 12:R36 (18 June 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| Editor’s summary Breast cancers of the basal-like, luminal A and luminal B molecular subtypes harbour specific methylation profiles, suggesting that methylation may play an important role in the development of breast cancers.
	Research article The role of chemotherapeutic drugs in the evaluation of breast tumour response to chemotherapy using serial FDG-PET Michal E Schneider-Kolsky, Stewart Hart, Jane Fox, Peter Midolo, John Stuckey, Michael Hofman, Vinod Ganju Breast Cancer Research 2010, 12:R37 (21 June 2010) Abstract \| Full text \| PDF \| PubMed
	Research article Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development Arusha Oloumi, Mykola Maidan, Frances E Lock, Howard Tearle, Steven McKinney, William J Muller, Samuel AJR Aparicio, Shoukat Dedhar Breast Cancer Research 2010, 12:R38 (21 June 2010) Abstract \| Full text \| PDF \| PubMed
	Research article Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer Karen J Taylor, Andrew H Sims, Liang Liang, Dana Faratian, Morwenna Muir, Graeme Walker, Barbara Kuske, J Michael Dixon, David A Cameron, David J Harrison, Simon P Langdon Breast Cancer Research 2010, 12:R39 (22 June 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	Research article Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer Chad J Creighton, Xiaoyong Fu, Bryan T Hennessy, Angelo J Casa, Yiqun Zhang, Ana Maria Gonzalez-Angulo, Ana Lluch, Joe W Gray, Powell H Brown, Susan G Hilsenbeck, C Kent Osborne, Gordon B Mills, Adrian V Lee, Rachel Schiff Breast Cancer Research 2010, 12:R40 (22 June 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	Research article RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells Joshua A Bauer, Fei Ye, Clayton B Marshall, Brian D Lehmann, Christopher S Pendleton, Yu Shyr, Carlos L Arteaga, Jennifer A Pietenpol Breast Cancer Research 2010, 12:R41 (24 June 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	Research article Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics Göran Jönsson, Johan Staaf, Johan Vallon-Christersson, Markus Ringnér, Karolina Holm, Cecilia Hegardt, Haukur Gunnarsson, Rainer Fagerholm, Carina Strand, Bjarni A Agnarsson, Outi Kilpivaara, Lena Luts, Päivi Heikkilä, Kristiina Aittomäki, Carl Blomqvist, Niklas Loman, Per Malmström, Håkan Olsson, Oskar Th Johannsson, Adalgeir Arason, Heli Nevanlinna, Rosa B Barkardottir, Åke Borg Breast Cancer Research 2010, 12:R42 (24 June 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| Editor’s summary The identification of six subtypes of breast cancer - differing in biology, genomic alterations and patient outcome - may prove useful for understanding tumor development and for prognostic and treatment prediction purposes.
	Research article The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells Hirokuni Ikeda, Naruto Taira, Fumikata Hara, Takeo Fujita, Hiromasa Yamamoto, Junichi Soh, Shinichi Toyooka, Tomohiro Nogami, Tadahiko Shien, Hiroyoshi Doihara, Shinichiro Miyoshi Breast Cancer Research 2010, 12:R43 (28 June 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	Research article Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer Cristina Cadenas, Dennis Franckenstein, Marcus Schmidt, Mathias Gehrmann, Matthias Hermes, Bettina Geppert, Wiebke Schormann, Lindsey J Maccoux, Markus Schug, Anika Schumann, Christian Wilhelm, Evgenia Freis, Katja Ickstadt, Jörg Rahnenführer, Jörg I Baumbach, Albert Sickmann, Jan G Hengstler Breast Cancer Research 2010, 12:R44 (28 June 2010) Abstract \| Full text \| PDF \| PubMed
	Correspondence
	Letter Association between the spread of circulating tumor cells and breast cancer subtypes Xiaowei Qi, Xinhua Yang, Linjun Fan, Yi Zhang, Fan Zhang, Jun Jiang Breast Cancer Research 2010, 12:402 (17 June 2010) Full text \| PDF \| PubMed

	Volume 12 Issue 3
	Comment
	Editorial At last, a predictive and prognostic marker for radiotherapy? Philip Coates, John Dewar, Alastair M Thompson Breast Cancer Research 2010, 12:106 (11 May 2010) Abstract \| Full text \| PDF \| PubMed
	Editorial Breast tumors: of mice and women Sean P McDermott, Max S Wicha Breast Cancer Research 2010, 12:108 (27 May 2010) Abstract \| Full text \| PDF \| PubMed
	Editorial What do we learn from HER2-positive breast cancer genomic profiles? Charles Theillet Breast Cancer Research 2010, 12:107 (1 June 2010) Abstract \| Full text \| PDF \| PubMed
	Editorial Just when you thought it was safe to go into the membrane: the growing complexities of extra-nuclear progesterone signaling Aritro Sen, Stephen R Hammes Breast Cancer Research 2010, 12:109 (16 June 2010) Abstract \| Full text \| PDF \| PubMed
	Editorial Managing bone mineral density with oral bisphosphonate therapy in women with breast cancer receiving adjuvant aromatase inhibition Catherine Van Poznak Breast Cancer Research 2010, 12:110 (18 June 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	Review
	Review Tumour-associated carbohydrate antigens in breast cancer Aurélie Cazet, Sylvain Julien, Marie Bobowski, Joy Burchell, Philippe Delannoy Breast Cancer Research 2010, 12:204 (8 June 2010) Abstract \| Full text \| PDF \| PubMed
	Review The contribution of dynamic stromal remodeling during mammary development to breast carcinogenesis Jessica McCready, Lisa M Arendt, Jenny A Rudnick, Charlotte Kuperwasser Breast Cancer Research 2010, 12:205 (17 June 2010) Abstract \| Full text \| PDF \| PubMed
	Review Key signalling nodes in mammary gland development and cancer. The Snail1-Twist1 conspiracy in malignant breast cancer progression Ellen Foubert, Bram De Craene, Geert Berx Breast Cancer Research 2010, 12:206 (25 June 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	Research
	Research article High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer Johan Staaf, Göran Jönsson, Markus Ringnér, Johan Vallon-Christersson, Dorthe Grabau, Adalgeir Arason, Haukur Gunnarsson, Bjarni A Agnarsson, Per-Olof Malmström, Oskar Johannsson, Niklas Loman, Rosa B Barkardottir, Åke Borg Breast Cancer Research 2010, 12:R25 (6 May 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| Editor’s summary A survey of copy number alterations in HER2+ breast tumors using a combination of array comparative genomic hybridization and gene expression analyses pinpoints significant genomic aberrations, including potentially novel therapeutic targets.
	Research article Cyclophosphamide- metabolizing enzyme polymorphisms and survival outcomes after adjuvant chemotherapy for node-positive breast cancer: a retrospective cohort study Priya P Gor, H Irene Su, Robert J Gray, Phyllis A Gimotty, Michelle Horn, Richard Aplenc, William P Vaughan, Martin S Tallman, Timothy R Rebbeck, Angela DeMichele Breast Cancer Research 2010, 12:R26 (10 May 2010) Abstract \| Full text \| PDF \| PubMed
	Research article Inhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cells Luisa Paris, Serena Cecchetti, Francesca Spadaro, Laura Abalsamo, Luana Lugini, Maria Elena Pisanu, Egidio Iorio, Pier Giorgio Natali, Carlo Ramoni, Franca Podo Breast Cancer Research 2010, 12:R27 (12 May 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	Research article Incorporating tumour pathology information into breast cancer risk prediction algorithms Nasim Mavaddat, Timothy R Rebbeck, Sunil R Lakhani, Douglas F Easton, Antonis C Antoniou Breast Cancer Research 2010, 12:R28 (18 May 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| Editor’s summary Including tumour pathology information in breast cancer prediction models influences the predicted probabilities of carrying a BRCA1 or BRCA2 mutation and may have implications for genetic testing and clinical decision making.
	Research article Novel design principles enable specific targeting of imaging and therapeutic agents to necrotic domains in breast tumors Liat Goldshaid, Efrat Rubinstein, Alexander Brandis, Dadi Segal, Noa Leshem, Ori Brenner, Vyacheslav Kalchenko, Doron Eren, Tamar Yecheskel, Yoseph Salitra, Yoram Salomon, Avigdor Scherz Breast Cancer Research 2010, 12:R29 (24 May 2010) Abstract \| Full text \| PDF \| PubMed
	Research article Breast cancer-specific mutations in CK1ε inhibit Wnt/β-catenin and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell adhesion and promote cell migration Silvie Foldynová-Trantírková, Petra Sekyrová, Kateřina Tmejová, Eva Brumovská, Ondřej Bernatík, Wulf Blankenfeldt, Pavel Krejčí, Alois Kozubík, Tomáš Doležal, Lukáš Trantírek, Vítězslav Bryja Breast Cancer Research 2010, 12:R30 (27 May 2010) Abstract \| Full text \| PDF \| PubMed
	Research article Senescence evasion by MCF-7 human breast tumor-initiating cells Feridoun Karimi-Busheri, Aghdass Rasouli-Nia, John R Mackey, Michael Weinfeld Breast Cancer Research 2010, 12:R31 (2 June 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| Editor’s summary Understanding the inherent down-regulation of senescence pathways that offer breast cancer tumour-initiating cells protection against ionising radiation may help characterise the cellular pathways used by cancer stem cells to enhance survival.
	Research article Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-α and survivin Kathryn E Vanderlaag, Susan Hudak, Laura Bald, Laurence Fayadat-Dilman, Manjiri Sathe, Jeff Grein, Mary J Janatpour Breast Cancer Research 2010, 12:R32 (4 June 2010) Abstract \| Full text \| PDF \| PubMed
	Research article Prospectively measured triiodothyronine levels are positively associated with breast cancer risk in postmenopausal women Ada Tosovic, Anne-Greth Bondeson, Lennart Bondeson, Ulla-Britt Ericsson, Johan Malm, Jonas Manjer Breast Cancer Research 2010, 12:R33 (11 June 2010) Abstract \| Full text \| PDF \| PubMed
	Research article Progesterone reverses the mesenchymal phenotypes of basal phenotype breast cancer cells via a membrane progesterone receptor mediated pathway Lian Zuo, Wei Li, Shaojin You Breast Cancer Research 2010, 12:R34 (11 June 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	Research article Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort Huiyan Ma, Katherine D Henderson, Jane Sullivan-Halley, Lei Duan, Sarah F Marshall, Giske Ursin, Pamela L Horn-Ross, Joan Largent, Dennis M Deapen, James V Lacey, Leslie Bernstein Breast Cancer Research 2010, 12:R35 (18 June 2010) Abstract \| Full text \| PDF \| PubMed
	Research article Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns Karolina Holm, Cecilia Hegardt, Johan Staaf, Johan Vallon-Christersson, Göran Jönsson, Håkan Olsson, Åke Borg, Markus Ringnér Breast Cancer Research 2010, 12:R36 (18 June 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| Editor’s summary Breast cancers of the basal-like, luminal A and luminal B molecular subtypes harbour specific methylation profiles, suggesting that methylation may play an important role in the development of breast cancers.
	Research article The role of chemotherapeutic drugs in the evaluation of breast tumour response to chemotherapy using serial FDG-PET Michal E Schneider-Kolsky, Stewart Hart, Jane Fox, Peter Midolo, John Stuckey, Michael Hofman, Vinod Ganju Breast Cancer Research 2010, 12:R37 (21 June 2010) Abstract \| Full text \| PDF \| PubMed
	Research article Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development Arusha Oloumi, Mykola Maidan, Frances E Lock, Howard Tearle, Steven McKinney, William J Muller, Samuel AJR Aparicio, Shoukat Dedhar Breast Cancer Research 2010, 12:R38 (21 June 2010) Abstract \| Full text \| PDF \| PubMed
	Research article Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer Karen J Taylor, Andrew H Sims, Liang Liang, Dana Faratian, Morwenna Muir, Graeme Walker, Barbara Kuske, J Michael Dixon, David A Cameron, David J Harrison, Simon P Langdon Breast Cancer Research 2010, 12:R39 (22 June 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	Research article Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer Chad J Creighton, Xiaoyong Fu, Bryan T Hennessy, Angelo J Casa, Yiqun Zhang, Ana Maria Gonzalez-Angulo, Ana Lluch, Joe W Gray, Powell H Brown, Susan G Hilsenbeck, C Kent Osborne, Gordon B Mills, Adrian V Lee, Rachel Schiff Breast Cancer Research 2010, 12:R40 (22 June 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	Research article RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells Joshua A Bauer, Fei Ye, Clayton B Marshall, Brian D Lehmann, Christopher S Pendleton, Yu Shyr, Carlos L Arteaga, Jennifer A Pietenpol Breast Cancer Research 2010, 12:R41 (24 June 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	Research article Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics Göran Jönsson, Johan Staaf, Johan Vallon-Christersson, Markus Ringnér, Karolina Holm, Cecilia Hegardt, Haukur Gunnarsson, Rainer Fagerholm, Carina Strand, Bjarni A Agnarsson, Outi Kilpivaara, Lena Luts, Päivi Heikkilä, Kristiina Aittomäki, Carl Blomqvist, Niklas Loman, Per Malmström, Håkan Olsson, Oskar Th Johannsson, Adalgeir Arason, Heli Nevanlinna, Rosa B Barkardottir, Åke Borg Breast Cancer Research 2010, 12:R42 (24 June 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central \| Editor’s summary The identification of six subtypes of breast cancer - differing in biology, genomic alterations and patient outcome - may prove useful for understanding tumor development and for prognostic and treatment prediction purposes.
	Research article The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells Hirokuni Ikeda, Naruto Taira, Fumikata Hara, Takeo Fujita, Hiromasa Yamamoto, Junichi Soh, Shinichi Toyooka, Tomohiro Nogami, Tadahiko Shien, Hiroyoshi Doihara, Shinichiro Miyoshi Breast Cancer Research 2010, 12:R43 (28 June 2010) Abstract \| Full text \| PDF \| PubMed \| Cited on BioMed Central
	Research article Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer Cristina Cadenas, Dennis Franckenstein, Marcus Schmidt, Mathias Gehrmann, Matthias Hermes, Bettina Geppert, Wiebke Schormann, Lindsey J Maccoux, Markus Schug, Anika Schumann, Christian Wilhelm, Evgenia Freis, Katja Ickstadt, Jörg Rahnenführer, Jörg I Baumbach, Albert Sickmann, Jan G Hengstler Breast Cancer Research 2010, 12:R44 (28 June 2010) Abstract \| Full text \| PDF \| PubMed
	Correspondence
	Letter Association between the spread of circulating tumor cells and breast cancer subtypes Xiaowei Qi, Xinhua Yang, Linjun Fan, Yi Zhang, Fan Zhang, Jun Jiang Breast Cancer Research 2010, 12:402 (17 June 2010) Full text \| PDF \| PubMed

Explore journal

Articles

Volume 12 Issue 3

Comment

Review

Research

Correspondence